Trial-in-Progress: Frontline Brentuximab Vedotin and CHP (A plus CHP) in Patients with Peripheral T-Cell Lymphoma with Less Than 10% CD30 Expression

Jagadeesh, D; Sims, RB; Horwitz, SM

BLOOD, 2020; 136 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索